Bowie Po‐Yee Wong
Hong Kong Science and Technology Parks Corporation(HK)University of Hong Kong(HK)
Publications by Year
Research Areas
interferon and immune responses, Cancer Immunotherapy and Biomarkers, Cancer, Hypoxia, and Metabolism, MicroRNA in disease regulation, Epigenetics and DNA Methylation
Most-Cited Works
- → Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses(2022)56 cited
- → CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma(2022)54 cited
- → Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development(2023)52 cited
- → Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer(2021)52 cited
- → Polo‐like kinase 4 inhibitor CFI‐400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity(2022)36 cited
- → Genome‐Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer Treatment(2022)33 cited
- → Inhibition of CAF-1 histone chaperone complex triggers cytosolic DNA and dsRNA sensing pathways and induces intrinsic immunity of hepatocellular carcinoma(2023)6 cited